公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B | Hsu C.-W.; Su W.-W.; Lee C.-M.; Peng C.-Y.; Chuang W.-L.; JIA-HORNG KAO ; Chu H.-C.; Huang Y.-H.; Chien R.-N.; Liaw Y.-F. | Journal of the Formosan Medical Association | 20 | 17 | |
1996 | Phylogenetic analysis of GB virus C: Comparison of isolates from Africa, North America, and Taiwan | JIA-HORNG KAO ; PEI-JER CHEN ; Hsiang S.-C.; Chen W.; DING-SHINN CHEN | Journal of Infectious Diseases | 51 | 52 | |
2014 | A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin | Hsu C.-S.; SHIH-JER HSU ; Lin H.H.; TAI-CHUNG TSENG ; Wang C.-C.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 7 | |
2014 | Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan | CHI-LING CHEN ; WEI-SHIUNG YANG ; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Chen C.-J. | Cancer Epidemiology Biomarkers and Prevention | 19 | 16 | |
2022 | Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities | Hsu, Yao-Chun; Tseng, Cheng-Hao; TUNG-HUNG SU ; JIA-HORNG KAO ; Nguyen, Mindie H | Gut | 3 | 2 | |
1997 | Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Journal of Medical Virology | 45 | | |
1994 | Possible role of high-titer maternal viremia in perinatal transmission of hepatitis c virus | HO-HSIUNG LIN ; JIA-HORNG KAO ; HONG-YUAN HSU ; YEN-HSUAN NI ; Shiou-Hwei Yeh ; Hwang L.-H.; MEI-HWEI CHANG ; Hwang S.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 180 | 140 | |
2001 | Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother | Chen J.-D.; Chung J.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 13 | 12 | |
2023 | Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection | TUNG-HUNG SU ; SHANG-CHIN HUANG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; YAO-MING WU ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2006 | Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma | Tong M.J.; Blatt L.M.; JIA-HORNG KAO ; Cheng J.T.; Corey W.G. | World Journal of Gastroenterology | 60 | 53 | |
2004 | Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis | CHUN-JEN LIU ; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Medical Virology | 39 | 37 | |
2015 | Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring system | Liu J.; TAI-CHUNG TSENG ; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; PEI-JER CHEN ; Chen C.-J.; JIA-HORNG KAO | Journal of Infectious Diseases | 16 | 13 | |
2018 | Preface | JIA-HORNG KAO ; DING-SHINN CHEN | Hepatitis B Virus and Liver Disease | 0 | 0 | |
2021 | Preface of the second edition | JIA-HORNG KAO | Hepatitis B Virus and Liver Disease | | | |
2017 | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 | Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; DING-SHINN CHEN ; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukšić B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morović M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonković D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; TUNG-HUNG SU ; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H. | Journal of Viral Hepatitis | 26 | 22 | |
2005 | Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan | Mah Y.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 17 | |
2016 | Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C | Mah Y.-H.; CHEN-HUA LIU ; CHI-LING CHEN ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 6 | 7 | |
2024 | Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease | Cheng, Kun-Lin; Wang, Shao-Wen; Cheng, Yu-Ming; Hsieh, Tsung-Han; Wang, Chia-Chi; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2002 | Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Infectious Diseases | 56 | 47 | |
1999 | Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan | JIA-HORNG KAO ; Chen W.; Hsiang S.-C.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 48 | | |